Abstract

Bacterial lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria that initiates inflammation by activation innate immune responses through Toll-like receptor 4 (TLR4). However, the influence of LPS on the mucosal immune reactions remains to be addressed. This study was examined the effect of LPS in nasal vaccination model. BALB/c and C57BL/6 mice were nasally immunized with keyhole limpet hemocyanin (KLH) conjugated with hapten phosphorylcholine (PC) or trinitrophenol (TNP) with LPS as a mucosal adjuvant, in the presence or absence of cholera toxin (CT). The antibody titers were measured in serum, saliva, and nasal wash fluids by an enzyme-linked immunosorbent assay (ELISA) in IgM, IgG, and IgA isotype-specific manner. The epitope-specific antibody production induced in blood and mucosal fluid was further enhanced by LPS for all isotypes examined. Besides, LPS, which has rarely been regarded as a mucosal adjuvant, was tested for its adjuvanticity by comparing the nasal immunization with PC-KLH plus LPS or with PC-KLH plus CT. LPS showed high adjuvanticity almost equal to CT. Possible differences of LPS from CT as a mucosal adjuvant remains to be elucidated.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call